img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
June 1, 2019
img
Document Security Systems
(NYSE: DSS)

$5,859,593

Follow-On Offering
Sole Bookrunner

May 1, 2019
img
img
Medalist Diversified REIT
(Nasdaq: MDRR)

$9,199,167

Follow-On Offering
Sole Bookrunner

May 1, 2019
img
Jiayin Group Inc
(Nasdaq: JFIN)

$36,750,000

Follow-On Offering
Co-Manager

May 1, 2019
img
img
Medalist Diversified REIT
(Nasdaq: MDRR)

$1,299,998

Private Placement
Placement Agent

May 1, 2019
img
img
Genetic Technologies
(Nasdaq: GENE)

$1,180,917


Sole Bookrunner

April 1, 2019
img
img
Monaker Group
(Nasdaq: MKGI)

$1,740,000

Follow-On Offering
Co-Manager

img
img
Golden Matrix Group Inc.
(OTCPK: GMGI)

$10,000,000

Underwritten Public Offering
Sole Bookrunner

img
img
Unicycive Therapeutics Inc.
(Nasdaq: UNCY)

Initial Public Offering
Lead Manager

1 33 34 35
Insights
  • May 22, 2025

    D. Boral Capital acted as Exclusive Placement Agent to Luminar Technologies (NASDAQ: LAZR) in connection with its up to $200.0 Million Equity Linked Securities Offering

  • May 13, 2025

    D. Boral Capital Acted as Capital Markets Advisor to Global Star Acquisition Inc. (NYSE: GLST) in connection with its Completed Business Combination with K Enter Holdings Inc.

  • May 12, 2025

    D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) in connection with its $13.5 Million Initial Public Offering

  • May 7, 2025

    D. Boral Capital is Acting as Exclusive Placement Agent to Nature’s Miracle Holding Inc. (OTCQB: NMHI) in connection with its Private Placement for up to $20 Million

img

Together, let's build meaningful value.